Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Hyloris Pharmaceuticals (0AB6)

Hyloris Pharmaceuticals Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0AB6
DateTimeSourceHeadlineSymbolCompany
14/03/202406:00UK RegulatoryHyloris Présente ses Résultats Annuels pour 2023 et ses PerspectivesLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202406:00UK RegulatoryHyloris Reports Full Year Results for 2023 & Provides Business OutlookLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202405:59UK RegulatoryCommunication at the request of the FSMA on the transactions with QliniqLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202405:59UK RegulatoryCommuniqué à la requête de la FSMA sur les transactions avec QliniQLSE:0AB6Hyloris Pharmaceuticals Sa
08/03/202406:00UK RegulatoryHyloris to Report 2023 Full-Year Results on 14 March 2024LSE:0AB6Hyloris Pharmaceuticals Sa
08/03/202406:00UK RegulatoryHyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024LSE:0AB6Hyloris Pharmaceuticals Sa
27/02/202417:00UK RegulatoryHyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au CanadaLSE:0AB6Hyloris Pharmaceuticals Sa
27/02/202417:00UK RegulatoryHyloris Announces Launch of Maxigesic® IV in the U.S. and approval In CanadaLSE:0AB6Hyloris Pharmaceuticals Sa
14/02/202417:00UK RegulatoryHyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions DentairesLSE:0AB6Hyloris Pharmaceuticals Sa
14/02/202417:00UK RegulatoryHyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental ProceduresLSE:0AB6Hyloris Pharmaceuticals Sa
30/01/202406:00UK RegulatoryHyloris et Purna Female Healthcare Annoncent des Résultats Positifs de leur Essai Clinique de Phase 2 chez des Patientes atteintes de Candidose Vulvovaginale Aiguë (CVV)LSE:0AB6Hyloris Pharmaceuticals Sa
30/01/202406:00UK RegulatoryHyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)LSE:0AB6Hyloris Pharmaceuticals Sa
 Showing the most relevant articles for your search:LSE:0AB6

Your Recent History

Delayed Upgrade Clock